1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Identification of N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), an Homologue Derivative of

Identification of N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), an Homologue Derivative of

  1. Jatelka
    Analusis 1999 27 523-532

    Baudat Ph, Vicherat A, Viriot ML and Carre MC

    Abstract. Some of the various N-substituted derivatives of the MDA have become popular drugs of abuse (MDMA, MDEA) in Europe and in France. With the increasing seizures of MBDB, [N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine] a new homo-logue of MDMA and MDEA, forensic analysis of these controlled substances requires the use of powerful techniques to charac-terize them. Analysis by either high performance liquid chromatography (HPLC) or capillary gas chromatography (CGC) allows the separation of MDMA, MDEA, MBDB and EBDB. The isomers MDEA and MBDB are best differentiated by either nuclear magnetic resonance spectroscopy (1H-NMR) or the combination of mass spectra (MS) and retention time (CGC). These tech-niques were successfully applied to seized tablets.